UV Flu Technologies, Inc. (UVFT) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerUV Flu Technologies, Inc. (UVFT) trades at $0.0002. UV Flu Technologies, Inc. specializes in air purification systems, utilizing UV technology to eliminate harmful microbes. Sector: Industrials.
Price as of · Last analyzed: Mar 17, 2026Analyst Coverage for UVFT: UVFT does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
UV Flu Technologies, Inc. (UVFT) Industrial Operations Profile
UV Flu Technologies, Inc. develops and sells air purification systems, including the ViraTech UV-400, which uses UV radiation to destroy harmful microbes. Targeting sectors like hospitality and healthcare, the company differentiates itself through advanced disinfection technology beyond traditional filtration.
What Is the Investment Thesis for UVFT?
UV Flu Technologies operates in the pollution and treatment controls industry, with a focus on air purification. The company's gross margin stands at 25.4%. With a market capitalization of $0.00B and negative free cash flow of $-0.00B, the company's financial position requires careful consideration. A key value driver is the increasing demand for air purification technologies, driven by growing awareness of airborne pathogens and indoor air quality. Upcoming catalysts include potential partnerships with larger HVAC companies and expansion into new markets. Potential risks include competition from established players and the need for continuous innovation to maintain a competitive edge.
Based on FMP financials and quantitative analysis
UVFT Key Highlights
Gross Margin of 25.4% reflects the company's profitability on sales after accounting for the cost of goods sold.
- Market Cap of $0.00B indicates the company's small size and potential for growth or volatility.
- Negative Free Cash Flow of $-0.00B suggests the company is currently spending more cash than it is generating.
- Beta of -65.43 indicates an inverse correlation to the market, though the magnitude raises questions about its reliability.
- Focus on UV-C technology provides a differentiated approach to air purification, targeting microbe destruction rather than just filtration.
Who Are UVFT's Competitors?
UVFT is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| TOMZ TOMI Environmental Solutions, Inc. | $1.38 | -0.36% | $10.6M | — |
| LIQT LiqTech International, Inc. | $0.47 | -9.14% | $17.2M | — |
| CLIR ClearSign Technologies Corporation | $3.56 | +1.42% | $22.1M | — |
| ZONE ZONE | $0.14 | +4.10% | $29.2M | — |
| BCHT Birchtech Corp. | $1.51 | +0.67% | $39.5M | — |
| FTEK Fuel Tech, Inc. | $1.66 | -0.30% | $51.7M | 36 5-pillar |
| SCWO 374Water, Inc. | $2.91 | -5.52% | $53.9M | — |
| ARQ Arq, Inc. | $1.95 | +0.52% | $83.3M | 30 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are UVFT's Key Strengths?
Proprietary UV-C technology for microbe destruction.
- Targeted solutions for specific industries.
- Established presence in niche markets.
- Focus on air purification beyond traditional filtration.
What Are UVFT's Weaknesses?
Small market capitalization.
- Negative free cash flow.
- Limited brand awareness.
- Dependence on a small number of products.
What Are the Key Risks for UVFT?
Financial-distress signal — its Altman Z-Score of -49.15 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Competition from larger, more established companies with greater resources.
- Technological advancements that could render existing UV-C technology obsolete.
- Changes in regulations and standards related to air purification.
- Economic downturn that could reduce demand for air purification systems.
- The company's small size and limited financial resources may hinder its ability to compete effectively.
What Are UVFT's Competitive Advantages?
- Proprietary UV-C technology in the ViraTech UV-400 provides a differentiated approach to air purification.
- Focus on microbe destruction rather than just filtration.
- Targeted solutions for specific industries and applications.
- Established presence in niche markets like salons and kennels.
What Does UVFT Do?
UV Flu Technologies, Inc., founded in 2006 and based in Lincolnshire, Illinois, researches, develops, manufactures, and sells air purification systems and products, primarily in the United States. Originally known as Northwest Chariots Incorporated, the company rebranded in November 2009 to reflect its focus on UV-based air purification technology. Their flagship product, the ViraTech UV-400, employs high-intensity germicidal ultraviolet radiation within a specialized chamber to trap and destroy harmful microbes, going beyond simple filtration. In addition to the ViraTech UV-400, UV Flu Technologies offers the RX Air product line, which includes HEPA-based air purifiers. These products are designed for use in a variety of settings, including hotels, hair and nail salons, pet kennels, test labs, hospitals, restaurants, casinos, and military installations, addressing the need for improved air quality and disinfection in diverse environments. The company aims to provide solutions that enhance air safety and reduce the spread of airborne pathogens.
What Products and Services Does UVFT Offer?
- Researches and develops air purification systems.
- Manufactures air purification products.
- Sells air purification systems primarily in the United States.
- Offers the ViraTech UV-400, which uses UV radiation to destroy microbes.
- Provides RX Air product line, including HEPA-based air purifiers.
- Targets commercial and institutional customers.
- Aims to improve indoor air quality and reduce airborne pathogens.
How Does UVFT Make Money?
- Direct sales of air purification systems to businesses and institutions.
- Revenue from the sale of ViraTech UV-400 and RX Air products.
- Potential for recurring revenue through filter replacements and maintenance services.
- Customized solutions for specific industry needs.
What Industry Does UVFT Operate In?
UV Flu Technologies operates within the pollution and treatment controls industry, which is experiencing growth due to increasing awareness of air quality and health concerns. The market includes established players offering traditional filtration systems and emerging companies focusing on advanced technologies like UV-C disinfection. UV Flu Technologies differentiates itself with its ViraTech UV-400, which uses UV radiation to destroy microbes. The competitive landscape includes companies like Donaldson Co. and Clarcor, which offer a range of filtration solutions.
Who Are UVFT's Key Customers?
- Hotels seeking to improve air quality for guests.
- Hair and nail salons requiring air purification to reduce chemical odors and particles.
- Pet kennels aiming to control odors and airborne allergens.
- Test labs and hospitals needing sterile environments.
- Restaurants and casinos wanting to improve air quality for patrons.
- Military installations requiring air purification for personnel.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Financial Health
UV Flu Technologies, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -49.15 places it in the distress zone, a signal of elevated financial risk.
Key Financial Metrics
Return on equity for UV Flu Technologies, Inc. stands at 137.8%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.16 means current liabilities exceed short-term assets, a liquidity point worth watching.
Company Profile
UV Flu Technologies, Inc. operates in the Industrials sector. It is headquartered in Lincolnshire, US. The company is led by CEO Michael S. Ross. UVFT has traded publicly since 2009.
UVFT Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
UVFT Latest News
No recent news available for UVFT.
UVFT Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for UVFT.
Price Targets
Wall Street price target analysis for UVFT.
UVFT MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for UVFT; grades run from A+ (80-100) to F (below 30).
UVFT OTC Market Information
UVFT trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
UV Flu Technologies, Inc. Industrials Stock: Key Questions Answered
What does UV Flu Technologies, Inc. do?
UV Flu Technologies, Inc. specializes in the development, manufacturing, and sale of air purification systems, primarily in the United States. They also offer the RX Air product line, which includes HEPA-based air purifiers.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Limited financial data available.
- Small market capitalization increases volatility.